The Food and Drug Administration has approved the world’s first medicine based on CRISPR gene-editing technology, a ...

N2K Networks is proud to announce the return of its flagship cybersecurity leadership podcast, CISO Perspectives on the N2K CyberWire network, with veteran CISO and educator Kim Jones as the new host.

The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an investigational gene editing therapy for adults with chronic hepatitis B.

The prospects for a one-time treatment that reduces the risk of heart disease for the rest of a person’s life just got brighter. In an initial trial, a single dose of a CRISPR gene-editing therapy ...